Previous studies have shown that distal mouse chromosome 1 contains the apolipoprotein All (apoAII) gene, encoding the second most abundant apolipoprotein in high density lipoproteins (HDLs), as well as a gene termed Ath-1 that controls aortic fatty streak development and HDL cholesterol levels in response to a high-fat, high-cholesterol diet. We report genetic studies confirming that the genes are distinct. Using molecular markers for mouse chromosome 1, we have further mapped the two genes, and our results indicate that they are separated by a minimum of 2 cM. We also report evidence that in mice on a low-fat chow diet, the apoAII gene locus influences HDL cholesterol levels. Thus, statistical analysis of two sets of recombinant inbred strains revealed concordant segregation patterns of HDL cholesterol levels and the apoAII gene locus. The effect of apoAII expression on HDL cholesterol levels was further tested by using a congenic strain that exhibits increased apoAII synthesis in comparison to the background strain. The results support the concept that increased synthesis of apoAII results in increased HDL cholesterol levels. Unexpectedly, increased expression of apoAII appeared to promote rather than retard aortic fatty streak are an important risk factor for coronary artery disease.
L ow plasma high density lipoprotein (HDL) levels
are an important risk factor for coronary artery disease.
1 -2 HDLs are a heterogeneous class of particles consisting of about equal parts lipid and protein. The major proteins of HDL are apolipoproteins AI and All (apoAI and apoAII). It has been hypothesized that HDLs protect against atherosclerosis by removing excess cholesterol from peripheral tissues and transporting it to the liver, a process termed "reverse cholesterol transport." 3 -4 HDL could also retard the development of atherosclerosis by virtue of its antioxidant properties. 5 That HDL directly affects lesion development is suggested by studies of rare individuals with null mutations of the apoAI gene who are unable to assemble HDL particles and who also develop premature coronary artery disease. 6 -7 This concept has received support from recent studies with transgenic mice that overexpress apoAI. These mice exhibited elevated levels of HDL and, in Plasma HDL levels vary widely between individuals. Biometric studies have shown that this variability is largely due to genetic factors, but efforts to understand these factors in humans have been complicated by environmental influences and genetic heterogeneity.7,9,10 studies of various rare genetic defects have shown that the genes for apoAI, lecithin: cholesterol acyl transferase (LCAT), and cholesteryl ester transfer protein (CETP) play important roles in HDL metabolism; however, together these defects account for only a small fraction of the genetic variance of HDL levels in the population. 411 The "candidate gene" approach, in which polymorphisms of biochemically relevant genes are correlated with phenotypes (HDL levels) in populations or families, has thus far yielded only suggestive evidence for the role of particular genetic loci in the control of HDL levels. 12 -14 Because of the difficulties in the direct analysis of complex genetic traits such as HDL levels in humans, we have studied the mouse model. Animal models provide important advantages for genetic as well as biochemical studies of complex traits, and genetic variations affecting lipoprotein metabolism and early atherosclerosis have been identified among inbred strains of mice. 1516 Previous studies have revealed a gene, designated Ath-1, that determines the development of early atherosclerotic lesions (fatty streaks) in response to a high-fat, high-cholesterol diet containing bile acids. The gene appears to act in part by determining HDL levels in response to the "atherogenic" diet; thus, most susceptible strains of mice, including C57BL/6J, show about a twofold decrease in HDL cholesterol (HDL-C) in response to the diet, whereas resistant strains exhibit little or no change in HDL-C levels when challenged with the diet. The identity of the Ath-1 gene is unknown, but it appears to be closely linked to the structural gene for apoAII (Apoa2)* on mouse chromosome I. 17 In the present report, we describe genetic loci that control the levels of HDLs in mice. One of these loci has proved to be the apoAII gene on chromosome 1. Alterations affecting the production of the apoAII polypeptide are shown to dramatically affect the levels of plasma HDL-C on a low-fat chow diet. Our results also conclusively establish that the Ath-1 and Apoa2 genes are distinct, and we report the use of molecular markers to refine the map positions of the genes. Interestingly, increased expression of apoAII appears to promote rather than retard fatty streak development. The implications of these results for studies of genetic factors that control HDL levels in humans are considered.
Methods

Animals and Diets
Mice were obtained from The Jackson Laboratory, Bar Harbor, Me. The recombinant inbred (RI) strains derived from parental strains NZB/B1NJ and SM/J (NXSM RI set) were generously provided by Dr. Eva Eicher, The Jackson Laboratory. Unless otherwise indicated, female mice 3-6 months of age were used. Normal chow was Purina chow containing 4% fat. The high-fat diet has previously been described 18 and was purchased from Teklad Test Diets, Madison, Wis. The diet contains, by weight, 7.5% cocoa butter, 1.25% cholesterol, and 0.5% cholic acid, with a total fat content of 15%. Mice were housed individually and maintained on a 12-hour light/dark cycle. They were fasted for 12 hours before they were killed and were bled 3-6 hours after the beginning of the light cycle.
Lipoprotein and Lipid Measurements
Plasma total cholesterol (TC), HDL-C, triglyceride (TG), nonesterified fatty acid (NEFA), and glycerol concentrations were determined by enzymatic procedures employing colorimetric end points. Combined low density lipoprotein cholesterol (LDL-C) plus very low density lipoprotein cholesterol (VLDL-C) concentration was determined by subtracting the HDL-C value from the TC value. All assays were run in 96-well microtiter plates (Costar No. 3598) with a Biomak 1000 Automated Laboratory Workstation (Beckman). Samples were diluted with saline so that their measured absorbance values were in the linear range of established standard curves. Measured absorbances were divided by the absorbance of a single standard concentration near the midpoint of the linear range of the established standard curve. The product of this factor and the standard concentration yielded the unknown value. Values were expressed as milligrams per deciliter. Each sample was measured in quadruplicate. An external control sample with a known analytic concentration (Accutrol, Sigma No. 2034) was run in each plate to assure accuracy. TC was determined according to Allain "The designation of the apolipoprotein All gene is Apoa2.
et al, 19 as provided in a kit (Sigma procedure 352). HDL-C was separated from LDL-C+VLDL-C by precipitating the latter with phosphotungstic acid and magnesium chloride according to Marz and Gross 20 and Assmann et al. 21 Precipitation reagents were obtained in a kit (Sigma procedure 352-4). NEFAs were measured by a modification of the method of Okabe et al. 22 TG and glycerol levels were measured by using a kit from Sigma (GPO-Trinder, procedure 337). This method is a modification of the method of McGowen et al. 23 All reaction volumes were scaled down from recommended levels so that the entire reaction could be run in a microtiter well. Absorbances were measured with a Vmax plate reader (Molecular Devices) at 510 nm except for NEFAs, which were measured at 570 nm.
Statistical Methods
Probability estimates were calculated by using the STATVIEW program for a Macintosh personal computer. Detailed statistical analysis to identify genetic loci that contribute to lipoprotein levels in the NXSM and BXH sets of RI strains was performed by using the MAP-MAKER-QUANTITATIVE TRAIT LOCUS (QTL) program. 24 This program uses the method of maximum likelihood to calculate the most likely effect of a putative genetic locus that contributes to a phenotype and computes an odds ratio, the ratio of the likelihood that a genetic locus at a specific location contributes to the phenotype to the likelihood that such a locus does not contribute. The strength of evidence for the existence of such a genetic locus is expressed as an LOD score, which is the logarithm (base 10) of the odds ratio, MAPMAKER-QTL was developed for analysis of genetic back-crosses and F 2 crosses, but we have also found the program useful for analysis of data from RI strains. We thank Dr. S. Lincoln, Massachusetts Institute of Technology, for helpful consultation in the application of the program.
Genetic Mapping
Genomic DNA was prepared from mouse spleens and kidneys by standard methods. 25 Southern blot analysis was performed on 10 -jug samples of DNA after restriction enzyme digestion, electrophoresis on 0.9% agarose gels in 0.5 x TBE (1 x TBE is 0.05 M tris(hydroxymethyl)aminomethane, 0.05 M boric acid, and 1 mM EDTA), and transfer to Nytran filters. Filters were hybridized at 42° in 50% formamide as described 26 and washed at 65° in 0.1 x saline-sodium citrate (lx salinesodium citrate is 0.15 M NaCl and 0.015 M sodium citrate, pH 7). Mouse cDNA inserts were isolated by gel electrophoresis and labeled with [ 32 P]deoxycytidine triphosphate to a specific activity of 1 x 10 9 cpm//xg by the oligonucleotide random-priming procedure. 27 The genetic markers examined used cDNA progress for At-3,
2S
Fcgr2, 29 Apoa2, 30 Spna-1, 31 and Crry.
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Results
Segregation of HDL-C Levels With the ApoAII Gene Locus on Mouse Chromosome 1
Surveys of inbred strains of mice for HDL-C levels revealed that strain NZB/B1NJ exhibits unusually high levels compared with other strains. Thus, most inbred strains of mice (about 50 strains have been studied) exhibited plasma HDL-C levels of about 40-60 mg/dl when maintained on a chow diet (A. J. Lusis, unpublished data). In contrast, strain NZB/B1NJ mice exhibited levels of about 110-120 mg/dl. To examine the genetic basis of this difference a set of RI strains derived from the parental strains NZB/B1NJ and SM/J were studied. RI strains are constructed by inbreeding random F 2 animals from a genetic cross of two different parental strains, thereby fixing unique combinations of parental genes. RI strains have proved valuable for gene mapping, since tightly linked genes tend to cosegregate among the sets of RI strains. RI strains also offer an important advantage for analysis of quantitative traits and complex phenotypes, since multiple observations can be made on a particular recombinant genotype fixed in each member of the set of RI strains.
The plasma lipoprotein profiles of the parental strains are presented in Table 1 . The HDL-C level of the NZB/B1NJ parent is nearly threefold greater than that of the SM/J parent. The NZB/B1NJ parent also has increased levels of LDL+VLDL-C and reduced levels of plasma TGs compared with the SM/J parent ( Table  1) . Measurement of the intensities of a-(HDL) and /3-(LDL+VLDL) migrating lipoprotein bands observed after agarose gel electrophoresis of plasma followed by staining with the lipophilic dye oil red O yielded results entirely consistent with these solution assays (data not shown).
The levels of plasma lipoproteins were examined in 15 NXSM RI strains. Three to four female mice of each strain, maintained on both chow and high-fat, highcholesterol atherogenic diets, 17 were examined. With the exception of TC and HDL-C levels for mice on a chow diet, complex, non-Mendelian segregation patterns were observed for each of the traits on both diets (data not shown), indicating the involvement of multiple genetic elements. However, most NXSM strains exhibited HDL-C levels closely approximating those of one parent or the other in approximately a 1 to 1 ratio, consistent with the possibility that HDL-C levels in mice on a chow diet are determined by a single major gene ( Figure 1) . Comparison of the HDL-C levels with genetic markers typed among the NXSM RI set revealed an association with the mouse chromosome 1 marker, Mtv-27 ( Figure 1 ). Thus, in general, mice that inherited the NZB/B1NJ Mtv-27 allele exhibited high HDL-C levels, and mice that inherited the SM/J Mtv-27 allele exhibited low HDL-C levels ( Figure 1 ).
The significance of the association between the Mtv-27 locus and HDL-C levels was determined by several statistical methods. For example, one-factor analysis of variance yielded a highly significant probability value of 0.0004 for the association between HDL-C levels and the Mtv-27 marker. The significance of the association was also evaluated by the MAPMAKER-QTL program developed by Lander, Lincoln, and colleagues (Paterson et al 24 ). The program was developed for use in the identification of genetic loci that contribute to complex genetic traits in genetic back-crosses or F 2 crosses of inbred plants and animals. We have also found the program useful for analysis of quantitative data from RI strains of mice (M. Mehrabian, unpublished observations). Figure 2A shows the results of analysis of the HDL-C data by MAPMAKER-QTL. Plotted on the x axis are the chromosome 1 markers typed among the NXSM set in terms of the distance (in centimorgans [cM] ) from the centromere. The program calculates the probability of an observation, expressed as the LOD score, at 2-cM intervals. An LOD score of approximately 3 or greater is considered significant in the mouse. 24 The gene that controls HDL-C levels is most likely to reside in the region corresponding to the peak LOD score. These results support the notion that HDL-C levels in genetic crosses between the NZB/ B1NJ and SM/J strains are determined by a major gene located on mouse chromosome 1. Using the MAPMAKER-QTL program, we estimate that about 74% of the HDL-C variance can be explained by this locus on chromosome 1. Interestingly, the gene for mouse apoAII, the second major protein of HDL, maps to precisely this region, thus making it an excellent candidate. The observation of nonparental HDL-C levels among some members of the NXSM RI set (Figure 1 ) indicates that minor genes unlinked to the apoAII locus also affect HDL-C levels.
Statistical analysis of other plasma lipid parameters that were examined in the NXSM set of RI strains, including LDL+VLDL-C, TG, NEFA, and glycerol levels for mice on chow as well as atherogenic diets, failed to reveal any additional statistically significant associations with any of the more than 100 genetic loci typed among members of the NXSM RI set (data not shown). This is not surprising, since only loci with very large effects are likely to be identified by analysis of such relatively small genetic crosses. 24 Analysis of larger F 2 or back-crosses, however, may identify the loci controlling these plasma lipid parameters.
The aforementioned results with strains NZB/B1NJ and SM/J suggest that the apoAII gene locus controls HDL-C levels of mice on a chow diet. However, because of the relatively small number of NXSM RI strains available, it is important to confirm this conclusion by analysis of back-crosses, additional sets of RI strains, or congenic strains. One additional large set of RI strains that is known to differ in its expression of apoAII is derived from the parental strains C57BL/6J and C3H/ HeJ (BXH RI set). We previously showed that the Apoa2 gene allele from C3H/HeJ is expressed at about twice the level of the allele from C57BL/6J mice. This is due to a cw-acting alteration that controls the translational efficiency of the apoAII mRNA. 33 As a result, C3H/HeJ mice synthesize about twice as much apoAII as do C57BL/6J mice and have about twice the level of the protein in the circulation. The levels of HDL-C of C3H/HeJ mice on a chow diet are slightly higher than those in C57BL/6J mice (about 25%), but no data have been presented to show that this is due to the difference in apoAII expression. 33 Analysis of HDL-C levels in the set of BXH RI strains by the MAPMAKER-QTL program is shown in Figure 2B . As in the case of the NXSM data, a clear peak with a maximum LOD score of 3.7 was observed at the apoAII gene (designated Apoal) locus. Also, as in the case of the NXSM RI strains, multiple genetic loci appear to contribute to HDL-C levels, since nonparental levels (those differing significantly from both parents) were observed among some RI strains ( Figure 3 ).
These results strongly support the conclusion that genetic variations of the distal region of mouse chromosome 1 affect HDL-C levels. This region contains two genes that have previously been shown to control HDL metabolism. One is the Apoa2 gene that encodes apoAII and has been shown to influence the composition and size of HDL.
33
- 35 The other is the Ath-1 gene that determines the development of fatty streaks and HDL-C levels in mice that are maintained on a high-fat, high-cholesterol diet.
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Genetic Variants Affecting ApoAII Synthesis Determine HDL-C Levels
To test whether the Apoa2 or Ath-1 genes determine levels of HDL-C in mice on a chow diet, we used congenic strain B6.CJi-25 C , in which the region of chromosome 1 containing the apoAII gene from strain BALB/cJ was transferred, by a large number of backcrosses, onto the genetic background of C57BL/6J. The congenic strain was originally constructed to study the expression of the H-25 alloantigen gene, which is tightly linked to the apoAII gene. 35 The large number of back-crosses used for construction of B6.CJ/-25 C suggests that only a small region around the H-25 and apoAII genes is derived from BALB/cJ.
We have used genetic markers to determine the boundaries of the chromosomal region transferred from BALB/cJ onto the C57BL/6J background. For this purpose we used genetic markers that map near the apoAII gene to identify restriction fragment length polymorphisms differing between strains BALB/cJ and C57BL/6J (Table 2) . Useful polymorphisms for the following genes were identified and scored: At-3-4 cM-Fcgr2 -1 cMApoa2 -2 cM-Spna-1 -10 cM -Crry, with At-3 being most proximal to the centromere (Figure 4) . In molecular terms, 1 cM roughly corresponds to 1 megabase. In the B6.CM-25 C congenic strain, the At-3 and Crry markers exhibit the C57BL/6J background alleles, whereas the Fcgr2, Apoa2, and Spna-1 markers exhibit the BALB/cJ alleles. Thus, the breakpoints between the BALB/cJ donor region and the C57BL/6J background occur proximally between At-3 and Fcgr2 and distally between Spna-1 37 and Crry (Figure 4) . These results suggest that at least 99% of the genome (total size of =1,600 cM in the mouse) is derived from the C57BL/6J background strain.
The inbred strain BALB/cJ has the same structural allele as inbred strain C3H/HeJ. Thus, sequencing of the apoAII cDNAs from these strains has shown that C3H/HeJ and BALB/cJ mice have identical sequences differing from those of C57BL/6J mice by eight nucleotide substitutions and three conservative amino acid substitutions. 33 The levels of plasma apoAII among the strains reflect closely the differences in the rates of hepatic synthesis. Thus, strain C57BL/6J mice have plasma apoAII concentrations of 15 mg/dl, whereas strains C3H/HeJ, BALB/cJ, and B6.C. H-25 C have plasma apoAII concentrations of 34, 32, and 31 mg/dl, respectively. 33 If, indeed, apoAII expression determines HDL-C levels on a chow diet in the BXH set of RI strains, then the congenic strain should differ in HDL-C levels compared with the C57BL/6J background strain.
As has previously been reported, strains BALB/cJ and C57BL/6J have similar levels of HDL-C on a chow diet (Table 3) . For this reason, we had assumed that the alteration in apoAII expression did not significantly influence HDL-C levels. 33 In contrast, in two separate experiments the congenic strain B6.CJ/-25 C exhibited HDL-C levels that were 59% (experiment 1) or 61% (experiment 2) greater than that of strain C57BL/6J (/?<0.0001 in each experiment; Table 3 ). These results indicate that the apoAII gene locus controls HDL-C levels, consistent with the conclusion from analysis of the aforementioned RI strains. Most likely, this is due to altered expression of apoAII in B6.C//-25 C compared with C57BL/6J mice, although we cannot formally exclude the possibility of a separate gene that is tightly linked to the apoAII gene. As shown below, the effect on HDL-C levels cannot be due to the Ath-1 gene, since it maps outside the region derived from BALB/cJ. 93±2.4 (12) HDL, high density lipoprotein. Values are mean±SEM and are in milligrams per deciliter, with the number of animals in parentheses.
*Female mice about 4 months of age and maintained on a chow diet were studied. Experiments 1 and 2 were performed with separate animals, using different reagents and slightly different volumes and assay protocols.
These results further indicate that although strains C57BL/6J and BALB/cJ exhibit similar HDL-C levels, they differ at a minimum of two genes controlling HDL-C levels. One of these resides at the apoAII gene locus and increases HDL-C levels by about 60% in strains carrying the BALB/cJ apoAII allele compared with the C57BL/6J apoAII allele. Therefore, the strains must also differ at another compensating genetic locus or loci that increase HDL-C in C57BL/6J compared with BALB/cJ mice. The nature and location of this locus are unclear; however, it is possible that it is identical with Ath-1 (see below).
Relation Between the Ath-1 and Apoa2 Genes
The Ath-1 gene controls the development of fatty streak lesions in the proximal aorta in mice maintained on a high-fat, high-cholesterol atherogenic diet. 17 Strain C57BL/6J is highly susceptible to lesion development, whereas most other common strains, including BALB/cJ and C3H/HeJ, are relatively resistant. The Ath-1 gene was mapped to mouse chromosome 1, near the apoAII gene, by using RI strains derived from the parental strains BALB/cJ and C57BL/6J (CXB RI set) and strains C57BL/6J and C3H/HeJ (BXH RI set). Several of the RI strains exhibited apparent recombination between the apoAII and Ath-1 genes, suggesting that the two loci were not identical. 17 Moreover, analysis of a small number of B6.CH-25 0 congenic mice suggested that they were susceptible to lesion development, 17 although they carry the BALB/c apoAII allele. 34 Cosegregating with lesion development were HDL-C levels for mice on the atherogenic diet, suggesting that HDL-C levels may be causal in lesion development. 17 The importance of HDL levels in lesion development is supported by the observation that transgenic C57BL/6J mice that overexpress human apoAI, thereby increasing HDL-C levels, are resistant to lesion formation while on the atherogenic diet. 8 The fact that the apoAII gene controls HDL-C levels and the close proximity of the apoAII and Ath-1 genes raise the possibility that the apoAII gene may participate in the lesion phenotype. It is possible to construct models involving a major influence of the apoAII gene, which explain our previous results (A.J. Lusis, unpublished observations). In such models, the apparent recombination between the apoAII and Ath-1 genes can be explained by multiple unlinked loci that also exert a substantial background effect on lesion development. We have now tested this possibility by a detailed examination of lesion development and HDL-C levels in the B6.CJJ-25 0 congenic strain.
BALB/cJ, C57BL/6J, and B6.C.H-25
C mice were maintained on the atherogenic diet for 15 weeks, and hearts were sectioned on a cryostat. The number and size of oil red O-staining lesions were counted in the proximal region of the aorta as described. 38 ' 39 Despite the fact that all animals of each strain are genetically identical, considerable variation in lesion development was observed (Table 4) , necessitating study of a large number of individuals. The B6. c mice exhibited considerably greater lesion development than did BALB/cJ mice, despite the fact that both strains share the same apoAII allele. Interestingly, the congenic strain B6.CJ/-25 C exhibited lesion development that was greater than that of strain C57BL/6J (Table 4) . Although the difference did not reach statistical significance (/?=0.16), it was qualitatively apparent on microscopic examination, as the lesions in B6. c mice appeared more advanced and had larger numbers of foam cells than the lesions in C57BL/6J mice. As expected, the BALB/cJ mice exhibited substantially less lesion development than the C57BL/6J mice (Table 4) , although a few of the 14 animals studied exhibited relatively large lesions. The nature of the large nongenetic variation is unclear. Most likely, it reflects subtle (12) 217±13 (15) 215±29 (9) HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein. Values are mean±SEM, with number of animals in parentheses.
'Female mice of each strain were maintained on an atherogenic diet for 15 weeks. After dissection of the heart and proximal aorta, the size of oil red O-staining lesions in each animal was quantified by examining sequential sections of the proximal aorta. Results are presented as the total area of oil red O-staining area (area per section times the number of stained sections). Lipoprotein cholesterol levels were determined as described under "Methods." environmental influences, although all mice were housed in the same room and care was taken to minimize any differences. For example, mice were housed individually to minimize possible "social" effects. Conceivably, it could reflect developmental differences or possibly stochastic influences if a small number of probabilistic events, such as monocyte entry into the artery wall, were rate limiting in lesion development. A second, smaller experiment yielded similar conclusions, and animals maintained on chow diets were essentially free of lesions (data not shown). We conclude from these studies that the apoAII gene does not correspond to the Ath-1 gene, despite its close proximity and effect on HDL-C levels. This is consistent with previous findings. 17 Moreover, increased production of apoAII appears to enhance lesion development.
Another issue relates to the control of lipoprotein levels in mice on the atherogenic diet. In particular, does the association between HDL-C levels and lesion development result simply from the fact that the Apoa2 gene (which affects HDL-C levels) and the Ath-1 gene (which controls lesion development) are tightly linked on mouse chromosome 1? To examine this question we characterized lipoprotein profiles in BALB/cJ, C57BL/ 6J, and B6.C.H-25 C mice before and after feeding the atherogenic diet. After 3 weeks of feeding the atherogenic diet, both C57BL/6J and B6.C. H-25 C strains exhibited about a twofold reduction in HDL-C levels, whereas strain BALB/cJ showed only a slight decrease ( Figure 5 ). The levels of LDL+VLDL-C increased and total plasma TGs decreased similarly among the strains ( Figure 5 ). After 15 weeks on the atherogenic diet, strains C57BL/6J and B6.C.H-25 C exhibited similar depressed levels of HDL-C, whereas the levels in strain BALB/cJ were, by comparison, about twofold higher ( Table 4) . The strains exhibited similar increases in LDL+VLDL-C levels (Table 4) . We conclude that the effect of the apoAII gene on HDL-C levels is largely but perhaps not entirely neutralized by prolonged exposure to the atherogenic diet. The effect of the apoAII gene locus on HDL-C levels was also abolished by the atherogenic diet in the NZB/BlNJxSM/J genetic cross (data not shown).
The above results suggest that the effect of apoAII expression on lesion development in mice maintained on an atherogenic diet may be related to structural alterations of HDL rather than to changes in HDL-C levels per se. Consistent with this possibility are previous studies that indicate that the apolipoprotein compositions of HDL differ between the susceptible C57BL/6J strain mice and resistant BALB/cJ and C3H/ HeJ strain mice when maintained on atherogenic as well as chow diets. Thus, after 10 weeks on an atherogenic diet, the ratio of apoAII mass to apoAI mass in strains C3H/HeJ, BALB/cJ, and C57BL/6J was 0.14, 0.15, and 0.09, respectively. 36 The apparent size of HDL of the congenic strain B6.C. H-25 0 , as judged by polyacrylamide gradient gel electrophoresis, was similar to BALB/cJ rather than to C57BL/6J on both chow and atherogenic diets (Reference 33 and data not shown). Thus, it is likely that HDL particles of the B6.C.H-25 0 congenic strain are enriched for apoAII relative to HDL of the C57BL/6J background strain on atherogenic as well as chow diets.
Discussion
Our results have revealed that genetic variation at the apoAII gene locus on mouse chromosome 1 influences HDL-C levels for mice on a chow diet. They also provide strong confirmation that the apoAII gene is distinct from the closely linked Ath-1 gene. These findings, as well as the implications of our results for understanding the genetic determinants of HDL metabolism in humans, are discussed in turn below.
Role of the ApoAII Gene Locus in the Control of HDL-C Levels on a Low-fat Chow Diet
Genetic studies with RI strains and a congenic strain in which the apoAII locus has been transferred from one strain onto the genetic background of the other have revealed the surprising conclusion that the apoAII gene locus can substantially influence HDL-C levels in mice on a chow diet. Our studies also suggest that the analysis of multigenic traits may be approached by using RI strains, although the relatively small number of RI strains informative for a particular trait of interest is usually an important limitation. We were able to confirm our original conclusion with the NXSM set of RI strains by using a second large set of RI strains (BXH). In general, back-crosses or F 2 crosses should be used to confirm conclusions from analysis of complex traits in RI strains. Furthermore, our conclusion was strengthened by analysis of a congenic strain of mouse, B6.C.//-2J C , that carries a small chromosomal region including the apoAII gene that is derived from strain BALB/cJ on a genetic background of strain C57BL/6J. As predicted, the congenic strain exhibited significantly increased levels of HDL compared with the C57BL/6J strain (Table 3) .
It is likely that the apoAII gene itself is responsible for the effect on HDL-C levels. Unlike apoAI, apoAII is not absolutely required for HDL assembly. Only a subfraction of HDL particles contain apoAII, 4 and studies of a family with apoAII deficiency did not reveal any striking plasma lipoprotein phenotypes. 40 Also, various species such as the dog, pig, cow, and chicken contain very little or no apoAII in HDL, 4 suggesting that apoAII may have a minor role in HDL metabolism. There is, however, clear evidence that apoAII influences both the structural and functional properties of HDL. 4 While it is possible that a gene distinct from but tightly linked to the Apoa2 gene is responsible for our observations, this would be unexpected, given the very small chromosomal region around the apoAII gene that is present in the B6.C. H-25 C congenic strain. Moreover, recent studies with transgenic mice that overexpress mouse apoAII are consistent with the conclusion that increased apoAII synthesis results in increased HDL-C levels (L. Hedrick et al, unpublished observations).
The mechanism by which apoAII affects HDL-C levels could involve, in part, its effect on HDL size. As we previously reported, the BALB/c apoAII alleles result in a distribution of HDL particles with an average diameter of about 10.5 nm compared with about 9.5 nm for the C57BL/6J allele. 33 Assuming an average difference of 10% in particle diameter would yield a difference of about 25% in particle volume. Given that the HDL-C composition in the strains is similar (that is, the fraction of total particle mass that is cholesterol does not differ significantly), one would predict that HDL-C levels should increase by about 25% in response to the increase in apoAII expression. Since the levels of HDL-C in the congenic strain were increased by about 60%, there must be other influences of apoAII overexpression, perhaps relating to HDL catabolism or cholesterol flux. It is interesting to note that human studies support the concept that the catabolism of HDL is reduced for large compared with small HDL particles (see below). Since the apoAII alleles between BALB/cJ and C57BL/6J differ in amino acid sequence, it is also possible that structural differences of apoAII are involved. As yet, the structures of the NZB/B1NJ and SM/J genes have not been determined.
It is interesting that the influence of the apoAII locus on HDL-C levels was partially or entirely abolished when mice were maintained for a prolonged period on an atherogenic, high-fat, high-cholesterol diet. This may be related to our previous observation that the atherogenic diet represses the levels of apoAII mRNA in the liver. 36 Our results support the conclusion that the Ath-1 and apoAII gene loci independently regulate HDL-C levels. These findings provide a striking example of the importance of genetic-dietary interactions in the control of cholesterol metabolism.
Mouse Model of Early Atherosclerosis:
The Ath-1 Gene Inbred strains of mice differ in susceptibility to the development of fatty streak lesions in the proximal region of the aorta when maintained for about 15 weeks on an atherogenic diet containing high amounts of fat, 1.25% cholesterol, and bile acids. Recent histological studies suggest that after 15 weeks on an atherogenic diet the lesions in mice closely resemble "fatty streaks" observed in humans. 3941 The observation of apparent differences in genetic recombinant animals with regard to lesion development and the apoAII gene suggested that the Ath-1 and apoAII genes are distinct, but the large nongenetic variability of lesion development has made it difficult to rule out a role for the apoAII gene. The present studies have conclusively established that the apoAII and the Ath-1 genes are distinct. Thus, the congenic strain B6.C. H-25 C , which carries the BALB/cJ Apoa2 allele on the background of C57BL/6J, is clearly susceptible to lesion development.
By the use of molecular markers differing between "resistant" and "susceptible" strains, we have further defined the chromosomal locations of Ath-1 and Apoa2 (Figure 4) . Thus, while studies with RI strains have suggested that Apoa2 and Ath-1 are within about 5 cM, 17 Ath-1 must reside outside the chromosomal region derived from BALB/cJ in the B6.C.H-25 0 congenic. The identity of Ath-1 is unknown, and it may be necessary to use positional cloning to understand how it acts to control fatty streak development. The large nongenetic variability of lesion development will, however, make it difficult to localize the gene precisely from studies with genetic crosses.
An unexpected finding from these studies was that increased expression of apoAII, while increasing HDL-C levels in mice on a chow diet and also after 3 weeks on an atherogenic diet, appeared to increase the size and severity of aortic lesions (Table 4) . Interestingly, various in vitro studies have suggested that HDL particles containing both apoAII and apoAI are less effective in mediating cholesterol efflux from tissue culture cells than are HDL particles containing apoAI alone.
442 - 43 Since the BALB/cJ apoAII allele increases the ratio of apoAII to apoAI in HDL, 3336 our results are consistent with the concept that HDLs rich in apoAII function less efficiently in reverse cholesterol transport than do HDLs that are poor in apoAII. Thus, the mouse model may prove useful in examining the structural and functional heterogeneity of HDL particles. In this regard, studies of human apoAI transgenic mice have demonstrated that the difference in apolipoprotein synthesis can dramatically affect both HDL level and structure. 44 -
Human Studies
Family studies have demonstrated that a large proportion of the variance in HDL levels in human populations is due to genetic influences, but the mode of inheritance and the identity of the genes responsible are largely unknown. 7 ' 9 ' 10 In general, human studies of the genetic regulation of HDL metabolism are confounded by genetic heterogeneity, environmental influences, and other problems. 47 Also, the metabolic complexity and structural heterogeneity of HDL have made biochemical approaches difficult. Much of our current understanding of the genetic control of HDL levels in humans is derived from studies of rare genetic defects. In contrast to deficiency states for apoAI, 6 apoCII, lipoprotein lipase, LCAT, 4 and CETP, 48 a deficiency of apoAII does not dramatically influence plasma lipoprotein levels. 40 ApoAII expression may, nevertheless, exert an incremental effect on the levels of HDL in humans, as appears to be the case in mice. Although certain population studies with a relatively rare Msp I polymorphism have failed to reveal significant associations with HDL levels, 14 ' 49 one study showed an association with the ratio of apoAII to apoAI in HDL particles 50 that was entirely consistent with the observations in mice. 33 Recent metabolic studies of HDL apolipoproteins in human volunteers have revealed that variations in HDL levels are partially due to differences in fractional catabolic rates and the fact that large HDL particles with increased ratios of HDL-C to apoAI plus apoAII exhibit decreased fractional catabolic rates. 5152 This suggests that HDL composition may be important in controlling HDL levels. 51 In this respect, it is interesting that variations of apoAII expression have a dramatic effect on HDL composition and size in mice, 33 - 35 and there is also evidence for this in humans. 50 It should also be noted that apart from the effects on HDL levels, the composition of HDL is likely to affect its "functional states," including processes that influence the development of atherosclerosis. 4 Our finding that increased apoAII is associated with increased fatty streak development is preliminary and requires further study, but by affecting the composition of HDL, apoAII production could clearly affect processes such as reverse cholesterol transport. Taken together, it appears that additional studies of the possible influence of apoAII in controlling HDL-C levels and composition in humans are warranted. This would probably be best addressed by studies of haplotypes of the apoAII gene or by linkage analysis in families rather than population association studies. 13 
